Novavax, Inc. Share Price
NVAXNovavax, Inc. Stock Performance
Open $9.79 | Prev. Close $9.72 | Circuit Range N/A |
Day Range $9.63 - $10.00 | Year Range $5.01 - $11.96 | Volume 92,646 |
Average Traded $9.90 |
Novavax, Inc. Share Price Chart
About Novavax, Inc.
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Novavax, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
18-Mar-26 | $10.59 | $10.02 | -5.92% |
17-Mar-26 | $10.07 | $10.64 | +5.61% |
16-Mar-26 | $10.39 | $10.08 | -1.56% |
13-Mar-26 | $10.54 | $10.24 | -0.68% |
12-Mar-26 | $10.61 | $10.31 | -4.54% |
11-Mar-26 | $10.80 | $10.80 | +0.93% |
10-Mar-26 | $10.56 | $10.70 | +1.37% |